Dengue fever vaccine (1 of 2) under 60

Service Description

The Qdenga vaccine helps prevent dengue fever in people aged 4 and older and under 60 years of age. It's given in two doses, 0.5 mL each, with the second dose administered three months after the first. Some individuals should not receive this vaccine, including: - Those allergic to the vaccine's ingredients or who had a reaction to a previous dose. - People with immune deficiencies, including those on immune-suppressing treatments. - Individuals with symptomatic HIV or asymptomatic HIV with immune impairment. - Pregnant or breastfeeding women. Studies indicate protection lasts between 1 to 4.5 years after the second dose.